Muslih A I
Department of Pharmacology, College of Pharmacy, Hawler Medical University, Irag.
Glob J Health Sci. 2012 Jun 30;4(5):14-9. doi: 10.5539/gjhs.v4n5p14.
The angiotensin converting enzyme inhibitors (ACEIs) are a group of pharmaceuticals that are used primarily in treatment of hypertension and congestive heart failure, in some cases as the drugs of first choice. The renin-angiotensin system is activated in response to hypotension, decreased sodium concentration in the distal tubule, decreased blood volume and in renal sympathetic nerve stimulation. This study examines the effects of angiotensin converting enzyme inhibitor (Lisinopril) on blood pressure (BP) 131 ± 2.4 and proteinuria 0.198 ± 0.005 in Kurd hypertensive patients, mean arterial blood pressure and proteinuria excretion were measured weekly along the period of 12 weeks. Lisinopril significantly reduced mean arterial blood pressure, and attenuated proteinuria level in patients subjected to this study in lisinopril 10mg dose dependent manner (p<0.05, n=24). In conclusion, lisinopril is of beneficial of renoprotection and in lowering BP.
血管紧张素转换酶抑制剂(ACEIs)是一类主要用于治疗高血压和充血性心力衰竭的药物,在某些情况下作为首选药物。肾素-血管紧张素系统在低血压、远端小管钠浓度降低、血容量减少和肾交感神经刺激时被激活。本研究考察了血管紧张素转换酶抑制剂(赖诺普利)对库尔德高血压患者血压(BP)131±2.4和蛋白尿0.198±0.005的影响,在12周的时间里每周测量平均动脉血压和蛋白尿排泄量。赖诺普利以10mg剂量依赖性方式显著降低了本研究中患者的平均动脉血压,并减轻了蛋白尿水平(p<0.05,n=24)。总之,赖诺普利具有肾脏保护作用且能降低血压。